Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001213900-25-039262·Soleus Private Equity Fund III, L.P.
Schedule 13G ownership disclosure
Verastem Inc
Common Stock · CUSIP: 92337C203
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Soleus Private Equity Fund III, L.P.
Shares: 343,519.00 · Class: 0.7%
- Soleus Private Equity GP III, LLC
Shares: 343,519.00 · Class: 0.7%
- Soleus PE GP III, LLC
Shares: 343,519.00 · Class: 0.7%
- Soleus Capital Master Fund, L.P.
Shares: 592,300.00 · Class: 1.2%
- Soleus Capital, LLC
Shares: 592,300.00 · Class: 1.2%
- Soleus Capital Group, LLC
Shares: 592,300.00 · Class: 1.2%
- Soleus Capital Management, L.P.
Shares: 935,819.00 · Class: 1.8%
- Soleus GP, LLC
Shares: 935,819.00 · Class: 1.8%
- Guy Levy
Shares: 935,819.00 · Class: 1.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-039262
- Form type
- SCHEDULE 13G/A
- Filer
- Soleus Private Equity Fund III, L.P.
- CIK
- CIK 1955982
- Filed
- May 02, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership